|
==The Company== DiaGenic () is a Norwegian listed biotechnology company that was founded in 1998. The company develops tests for the early diagnosis of serious diseases. The Company's concept is based on the identification and clinical documentation of disease-specific gene signatures measured using normal blood samples. The first products from DiaGenic are tests for the early diagnosis of breast cancer (BCtect) and Alzheimer's disease (ADtect), to be followed by a test for Parkinson's disease (PDtect). In June 2009 DiaGenic released ADtect and BCtect as CE IVD Mark products for detection of breast cancer and Alzheimer's disease and consequently can start marketing the tests in EU and EFTA countries. Marketing and sales of the tests in Europe are to be managed by distributors, where the first distribution agreements are signed. Diagenic was awarded Norway`s most innovative company for 2009 by the Research Council of Norway.〔The Research Council of Norway http://www.rcn.no/servlet/Satellite?c=Nyhet&pagename=stamceller%2FHovedsidemal&cid=1253951988601〕 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「DiaGenic」の詳細全文を読む スポンサード リンク
|